Adherence Completed Phase 4 Trials for Calcipotriol (DB02300)

IndicationStatusPhase
DBCOND0032993 (Adherence)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02858713Adherence in Topical Treatment of PsoriasisSupportive Care